申请人:DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK
公开号:US10385016B2
公开(公告)日:2019-08-20
The invention relates to a compound of the general formula (I) N3O2S—Ar-L-Ar′—SO2N3, wherein: —Ar and Ar′ are aromatic building blocks; and —L is a linking group comprising at least one heteroatom as well as an organic chain denoted as Sp″ and having at least two carbon atoms. The invention also relates to a compound of the general formula (II) wherein: —Ar and Ar′ are aromatic building blocks; —L is a covalent bond or a linking group; —m and n are both 0 or 1, at least one of m and n being 1; —Sp and Sp′ are organic chains having at least two carbon atoms. The invention also relates to the use of these compounds as cross linking agents in the manufacture of polymers.
PYRAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS
申请人:Pfizer Japan Inc.
公开号:EP1495005A1
公开(公告)日:2005-01-12
NON EXPLOSIVE BIS-SULFONYL AZIDES
申请人:DYNAMIT NOBEL GMBH EXPLOSIVSTOFF- UND SYSTEMTECHNIK
公开号:US20180050988A1
公开(公告)日:2018-02-22
The invention relates to a compound of the general formula (I) N
3
O
2
S—Ar-L-Ar′—SO
2
N
3
, wherein: —Ar and Ar′ are aromatic building blocks; and —L is a linking group comprising at least one heteroatom as well as an organic chain denoted as Sp″ and having at least two carbon atoms. The invention also relates to a compound of the general formula (II) wherein: —Ar and Ar′ are aromatic building blocks; —L is a covalent bond or a linking group; —m and n are both 0 or 1, at least one of m and n being 1; —Sp and Sp′ are organic chains having at least two carbon atoms. The invention also relates to the use of these compounds as cross linking agents in the manufacture of polymers
US7001917B2
申请人:——
公开号:US7001917B2
公开(公告)日:2006-02-21
[EN] PYRAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS<br/>[FR] COMPOSES DE PYRAZOLE EN TANT QU'AGENTS ANTI-INFLAMMATOIRES ET ANALGESIQUES
申请人:PFIZER PHARMA
公开号:WO2003087061A1
公开(公告)日:2003-10-23
This invention provides a compound of the formula (I): wherein: R1 represents a hydrogen atom, an alkyl group, etc.; R2 represents a hydrogen atom, a halogen atom, etc.; R3 represents an alkyl group, etc.; R4 represents an aryl group, etc.; A represents an aryll, etc; B represents an alkylene etc.; X represents NH, etc.; or a pharmaceutically acceptable ester of such compound, and pharmaceutically acceptable salts thereof. These compounds are useful for the treatment of medical conditions mediated by prostaglandin such as pain, fever or inflammation, etc. This invention also provides a pharmaceutical composition comprising the above compound.